GrowthLoop Expands AI Decisioning Capabilities Into Biopharmaceutical Marketing, Turning Customer Context Into Smarter Campaigns for Healthcare Providers
Continuous experimentation informs AI decisions on when and how to engage healthcare professionals NEW YORK, Nov. 4, 2026 /PRNewswire/ -- GrowthLoop, a pioneer in agentic AI-powered marketing solutions, and EVERSANA®, a leading independent provider of global services to the life sciences...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 79 stories mentioning NOV, the earliest published 7 Oct 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.